Company Filing History:
Years Active: 2004-2013
Title: The Innovative Contributions of James MacDowell Markert
Introduction
James MacDowell Markert is a notable inventor based in Birmingham, AL (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Markert's work focuses on utilizing herpes simplex virus vectors for therapeutic purposes.
Latest Patents
Markert's latest patents include a groundbreaking anti-cancer pharmaceutical composition that incorporates a herpes simplex virus (HSV) vector. This vector is engineered to express foreign genes, specifically nucleic acid sequences encoding for anti-cancer agents such as interleukin-12, GM-CSF, and CD. The method of treatment involves administering this anti-tumor pharmaceutical composition to patients suffering from cancer, showcasing a novel approach to cancer therapy.
Career Highlights
Markert is affiliated with the UAB Research Foundation, where he continues to advance his research in the field of oncology. His work has the potential to revolutionize cancer treatment by providing new avenues for therapeutic intervention.
Collaborations
Throughout his career, Markert has collaborated with esteemed colleagues, including Richard J. Whitley and George Yancey Gillespie. These partnerships have further enriched his research and contributed to the development of innovative solutions in cancer treatment.
Conclusion
James MacDowell Markert's contributions to the field of cancer research through his patented inventions highlight the importance of innovation in medical science. His work exemplifies the potential of using viral vectors for therapeutic applications, paving the way for future advancements in cancer treatment.